Stock listing
NASDAQ:IBRX ImmunityBio, Inc. Stock
Home listing (NASDAQ) of ImmunityBio, Inc.
Follow ImmunityBio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IBRX
$10.00 USD +0.09 (+0.9%)
Delayed at least 15 minutes · 4:42 PM EDT, Oct 15, 2026
- Ticker
- NASDAQ:IBRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 33 slides
Latest news
Decks
Investor Presentation (August 2026)
Investor deck · 33 slides · August 2026
Milken Institute Presentation 2026
Conference · 67 slides · Feb 24, 2026
Investor Presentation (November 2022)
Investor deck · 30 slides · Nov 15, 2022
Investor Presentation (June 2021)
Investor deck · 58 slides · Jun 4, 2021
ImmunityBio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 47 in the last 12 months · 201 in all · newest Oct 14, 2026 · oldest 2019
- Decks
- 9 decks · latest August 2026
Where ImmunityBio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IBRX · Home listing · This page | NASDAQ | United States | USD |
| gettex:26CA | gettex | Germany | EUR |
| LS Exchange:A2QQ2E | LS Exchange | Germany | EUR |
| Tradegate:26CA | Tradegate | Germany | EUR |
| BOATS:IBRX | BOATS | United States | USD |
| Frankfurt:26CA | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QQ2E | Lang & Schwarz | Germany | EUR |
| Dusseldorf:26CA | Dusseldorf | Germany | EUR |
| Stuttgart:26CA | Stuttgart | Germany | EUR |
| Munich:26CA | Munich | Germany | EUR |
| Hamburg:26CA | Hamburg | Germany | EUR |
| Hanover:26CA | Hanover | Germany | EUR |
| Xetra:26CA | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about ImmunityBio, Inc.